Analysts Set Xylem Inc. (NYSE:XYL) Target Price at $132.56

Xylem Inc. (NYSE:XYLGet Free Report) has been assigned a consensus rating of “Moderate Buy” from the eleven ratings firms that are currently covering the stock, MarketBeat Ratings reports. Three analysts have rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average 12 month price target among analysts that have covered the stock in the last year is $134.00.

Several research analysts have recently commented on the stock. BNP Paribas assumed coverage on shares of Xylem in a research note on Tuesday, March 12th. They issued an “outperform” rating and a $150.00 price objective for the company. Wolfe Research assumed coverage on shares of Xylem in a research note on Wednesday, December 13th. They issued an “outperform” rating and a $127.00 price objective for the company. Raymond James raised shares of Xylem from an “underperform” rating to a “market perform” rating in a research note on Thursday, January 4th. Stifel Nicolaus raised their target price on shares of Xylem from $136.00 to $150.00 and gave the company a “buy” rating in a report on Wednesday, February 7th. Finally, Royal Bank of Canada raised their target price on shares of Xylem from $140.00 to $145.00 and gave the company an “outperform” rating in a report on Wednesday, February 7th.

Read Our Latest Research Report on Xylem

Xylem Trading Down 0.7 %

Shares of XYL stock opened at $129.14 on Wednesday. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.76 and a quick ratio of 1.30. The firm has a market cap of $31.22 billion, a PE ratio of 47.48, a price-to-earnings-growth ratio of 2.61 and a beta of 1.11. The company has a 50-day moving average of $121.63 and a two-hundred day moving average of $107.60. Xylem has a 1-year low of $87.59 and a 1-year high of $130.86.

Xylem (NYSE:XYLGet Free Report) last announced its earnings results on Tuesday, February 6th. The industrial products company reported $0.99 earnings per share for the quarter, topping the consensus estimate of $0.96 by $0.03. Xylem had a net margin of 8.27% and a return on equity of 9.65%. The company had revenue of $2.12 billion during the quarter, compared to analyst estimates of $2.05 billion. During the same quarter last year, the firm posted $0.92 earnings per share. Xylem’s revenue was up 40.6% compared to the same quarter last year. On average, analysts predict that Xylem will post 4.13 EPS for the current year.

Xylem Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, March 20th. Shareholders of record on Wednesday, February 21st were issued a dividend of $0.36 per share. The ex-dividend date was Tuesday, February 20th. This represents a $1.44 dividend on an annualized basis and a yield of 1.12%. This is a boost from Xylem’s previous quarterly dividend of $0.33. Xylem’s dividend payout ratio (DPR) is presently 52.94%.

Insiders Place Their Bets

In other Xylem news, SVP Franz Cerwinka sold 2,408 shares of the firm’s stock in a transaction that occurred on Thursday, February 8th. The shares were sold at an average price of $121.79, for a total transaction of $293,270.32. Following the sale, the senior vice president now owns 11,750 shares of the company’s stock, valued at $1,431,032.50. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other news, CAO Geri-Michelle Mcshane sold 1,000 shares of Xylem stock in a transaction on Tuesday, February 20th. The shares were sold at an average price of $122.89, for a total value of $122,890.00. Following the transaction, the chief accounting officer now directly owns 2,935 shares of the company’s stock, valued at approximately $360,682.15. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Franz Cerwinka sold 2,408 shares of Xylem stock in a transaction on Thursday, February 8th. The shares were sold at an average price of $121.79, for a total transaction of $293,270.32. Following the completion of the transaction, the senior vice president now directly owns 11,750 shares in the company, valued at $1,431,032.50. The disclosure for this sale can be found here. 0.90% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Xylem

Hedge funds and other institutional investors have recently bought and sold shares of the company. ING Groep NV purchased a new position in Xylem in the 3rd quarter valued at $2,752,000. Meiji Yasuda Asset Management Co Ltd. boosted its position in shares of Xylem by 6.6% during the 3rd quarter. Meiji Yasuda Asset Management Co Ltd. now owns 39,266 shares of the industrial products company’s stock worth $3,574,000 after purchasing an additional 2,438 shares in the last quarter. Mariner LLC boosted its position in shares of Xylem by 10.3% during the 3rd quarter. Mariner LLC now owns 75,036 shares of the industrial products company’s stock worth $6,831,000 after purchasing an additional 7,006 shares in the last quarter. Cambridge Trust Co. boosted its position in shares of Xylem by 3.0% during the 3rd quarter. Cambridge Trust Co. now owns 156,815 shares of the industrial products company’s stock worth $14,275,000 after purchasing an additional 4,621 shares in the last quarter. Finally, CIBC Asset Management Inc boosted its position in shares of Xylem by 19.1% during the 3rd quarter. CIBC Asset Management Inc now owns 34,143 shares of the industrial products company’s stock worth $3,108,000 after purchasing an additional 5,465 shares in the last quarter. 84.53% of the stock is currently owned by hedge funds and other institutional investors.

Xylem Company Profile

(Get Free Report

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

See Also

Analyst Recommendations for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.